## Abstract Classification of highβrisk HPV types for cervical cancer screening depends on epidemiological studies defining HPV typeβspecific risk. The genotyping tests that are used, are however, not uniform with regard to typeβspecific detection rates making comparisons between different studies
Comparison of methods trial for high-risk HPV
β Scribed by Daniel F. I. Kurtycz; Michele Smith; Rong He; Kayo Miyazaki; John Shalkham
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 75 KB
- Volume
- 38
- Category
- Article
- ISSN
- 8755-1039
- DOI
- 10.1002/dc.21161
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Cytological cervical screening is rather inefficient because of relatively high proportions of false negative and false positive smears. To evaluate the efficiency of highβrisk human papillomavirus (hrHPV) testing, by GP5+/6+ PCRβenzyme immunoassay (EIA), in conjunction with cytology (I
A population-based study was conducted on 256 southern Chinese with cervical intraepithelial neoplasia grade III (CIN III) or invasive cervical cancer (ICC) and on 258 controls to examine the associations between HLA-B alleles, infection with high-risk human papillomaviruses (HPVs) and the developme
## Abstract ## __Background.__ Cidofovir is a nucleoside analogue that is used offβlicense to treat recurrent respiratory papillomatosis (RRP) caused by HPV6/11. However, the effect of this drug upon lowβrisk HPV 6/11 gene expression is unknown. ## __Methods.__ The expression of E6 was evaluated